drugset / Trial / NCT03603938

Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern

NCT03603938 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Nondipping blood pressure (BP) pattern is a potential independent risk factor for chronic kidney disease (CKD). Whether bedtime administration of potassium losartan has benefit for anti-hypertension and the prognosis of CKD patients is not clear. Patients with nondipping BP pattern or dipping BP pattern were enrolled in this study, and the patients with nondipping BP pattern were randomly divided into two groups and treated with bedtime or awakening doses of potassium losartan.

Timeline

Start
2018-11-01
Primary completion
2023-06-30
Completion
2023-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject potassium losartan Unknown — —